Skip to main content

Table 3 Multivariate analysis of PFS association with clinical parameters

From: Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy

Clinical parameter

Multivariate analysis

HR (95% CI)

P value

Tau expression

  

o negative

NS

NS

o positive

FIGO stage at diagnosis

  

o Early (I,II)

NS

NS

o Advanced (III,IV)

Histopathologic cell type

  

o serous

NS

NS

o others

Residual tumor size

  

o<1 cm

2.84; (1.64-4.92)

0.0002

o> 1 cm

  1. Abbreviations: HR- hazard ratio, NS – not significant.